Eyeing a better 2010, Codexis re-files for IPO

After withdrawing its first attempt at an IPO in September 2008 (citing unfavorable market conditions as its reason), biocatalyst producer Codexis closed out 2009 by filing a new S-1, proposing an initial public offering worth $100 million. Codexis' partners include Merck, Pfizer, Dr. Reddy's Labora...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Grab goes public in largest SPAC deal as merger talks with Gojek fail

News Commentary | April 08, 2021

Several rounds of rumors had suggested Grab and Gojek were nearing a merger. In a turn of events, Grab, Southeast Asia's largest startup, will likely raise more than $2 billion in funding by going public via the SPAC model through Altimeter. Financing from Ant Financial fell through along with the ... To read more, click here.

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

G2 Venture closes $500 million fund targeting climate change-mitigating technologies but still lacks deep decarbonization startups

News Commentary | July 08, 2021

Last month, G2V announced the close of a $500 million fund following its inaugural $350 million fund in 2017. Continuing with its original investment thesis, G2V will target companies active in the energy, manufacturing, logistics, transportation, and agriculture industries, with an emphasis on "... Not part of subscription